Sorry, but this content is restricted to our subscribers.
If you are having an issue with your account, then please get in touch with us.
Amcor looks oversold and we expect to see a rally back to $14.00 over the next 8 weeks.
Amcor announced a proposal to acquire Bemis in August, when the deal was valued at about $9 billion.
Bemis operates 56 packaging plants in 12 countries but most of its operations are in the USA; Amcor operates 195 packaging plants in 43 countries.
Amcor will shift its main share-market listing to the New York Stock Exchange in the all-scrip buyout, which would make it the world’s largest plastic packaging group.
It will ditch the ASX as its primary home, but still intends to give Australian shareholders exposure through Chess Depository Interests on the ASX.
We expect hedge funds to begin unwinding their short AMC long Bemis position which will create added buy-side demand into the market for AMC shares.
We recommend buying both Downer EDI & CIMIC Group at current levels.
Both of these infrastructure names have pulled back materially from their June highs without any negative changes to their growth prospects.
From a technical perspective, we see medium-term upside targets of $7.50 and $51.50, respectfully.
We recommend buying Medibank Private at current levels.
Since trading down to $2.62 on Monday, the stock has risen 6% and reached $2.79 in early trade today.
The internal momentum indicators are now pointing to resistance near $3.10.
Our ALGO engine triggered a buy signal for S32 last Friday at $3.51.
This “higher low” patterned is referenced to the intraday low of $3.35 posted on September 5th.
After a solid quarterly report two weeks ago, the share price spiked to a new all-time high of $4.28.
Since then, the share price has dropped over 17%, which is what triggered the ALGO signal last week.
S32 is a diversified miner and exports a range of minerals from Alumina to Manganese.
As such, we believe that S32 shares will find investor support above $3.00 for another run at the $4.00 handle over the medium-term.
CSR reports its 1HFY19 earnings on Friday and the market is looking for EBIT of $170 – $180 million for the 6 month period.
Boral, James Hardie and CSR have all been under pressure from short sellers and we are expecting to see some reversal of this trade.
The building stocks, in general, are looking oversold.
Ramsay Healthcare remains in a Algo Engine “sell” condition, however, after the share price correction from $85 to $52, we now see value beginning to emerge.
Shareholders in Swedish hospitals group Capio have given the approval to RHC’s 51% owned French subsidiary A$1.3bn takeover offer, to proceed.
With all conditions now satisfied, the deal’s expected settlement will be early next month.
Watch for RHC to turn positive and generate an Algo Engine buy signal in the coming months.
Our Algo Engine triggered a buy signal for IAG at $6.95.
This “higher low” pattern is referenced to the $6.56 low posted last October.
The stock is a current holding in our ASX 50 and ASX100 model portfolios.
With the share price trading sub $7.00 we consider value is now on offer.
IAG recently announced it had sold its operations in Thailand, Indonesia and Vietnam. Following this, the company indicated they would return $592 million of capital to shareholders.
In FY19, IAG will pay $0.195 capital return and a $0.055 special dividend.